Anti-SARS-CoV-2 RBD Reference Antibody (Rimteravimab, RUO)
Overview
| Catalog No. |
VK565166 |
| Host species |
Chimeric |
| Species reactivity |
SARS-CoV-2 (2019-nCoV) |
| Form |
Liquid |
| Storage buffer |
0.01M PBS, pH 7.4. |
| Purity |
>95% purity as determined by SDS-PAGE. |
| Clonality |
Monoclonal |
| Isotype |
[VH-h-CH2-CH3]-dimer |
| Applications |
ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Target |
Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2, Receptor-Binding Domain, RBD |
| Purification |
Protein A/G purified from cell culture supernatant. |
| Endotoxin level |
Please contact the lab for this information. |
| Expression system |
Mammalian Cells |
| Accession |
P0DTC2 |
| Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternative name |
VHH-72-Fc, XVR0112540797-21-3 |
| Note |
For research use only. Not suitable for clinical or therapeutic use. |
Images
 Bioactivity |
Detects Recombinant SARS-CoV-2 Spike protein receptor binding domain (Cat No.: VK565021) in indirect ELISA. |